Telos Partners is a group of seasoned scientific, regulatory and publication professionals who serve the life sciences industry.
With decades of combined experience ranging from start-up to large-cap environments, we thrive under pressure and savor the excitement of completing mission-critical projects.
Formulating and answering the research questions that define your technology
Earning clearances and claims for key indications to unlock your markets
Telling your story to health care decision-makers who need your evidence
The Latest News From Telos Partners
DENVER, December 12, 2017 (Newswire.com) – Global life sciences group Telos Partners LLC (telospartnersllc.com) is pleased to announce the appointment of Jason Inzana, Ph.D., as manager of Evidence Strategy and Development. In this role, Dr. Inzana will facilitate the ongoing growth of the Telos Partners brand and support the company’s mission of threading the needle Read more about Telos Partners Welcomes Jason Inzana, Ph.D., to Expand Strategic Capabilities Amid Rapid Growth[…]
Telos Partners will be attending NASS 2017 in Orlando later this month. Our schedule includes client-specific strategy sessions, as well as hosting exploratory meetings with companies looking to explore opportunities to improve efforts towards evidence generation and the development of quality publications / presentations in concert with their commercialization strategy. Contact us directly for more Read more about Telos Partners to Participate in NASS 2017 Annual Meeting[…]
JNJ | JLABS @Toronto, September 21, 2017: Telos Partners founder Joel Batts (center) moderating expert panel discussions with Jeff Muir, Intellijoint (left) and Katie Kleinschuster, Aesculap Implant Systems (right). Healthcare leaders from both start-ups and well-established organizations learned how they can leverage the benefits of developing and executing a long-term publication strategy, while recognizing clinical Read more about Telos Partners Moderates Panel Discussion at JLABS in Toronto[…]
Acera Surgical Selects Telos Partners to Develop and Manage Clinical Trial on Its Restrata™ Wound Matrix
DENVER, September 14, 2017 (Newswire.com) – Telos Partners, LLC, a firm providing scientific, regulatory and publication services to the life sciences industry, has been selected by Acera Surgical to lead its Restrata™ wound matrix study titled: “Clinical Outcomes after Treatment with Restrata™ in Diabetic Foot Ulcers (DFU): A Case Series of Initial Effectiveness and Safety Read more about Acera Surgical Selects Telos Partners to Develop and Manage Clinical Trial on Its Restrata™ Wound Matrix[…]